Intravenous cyclophosphamide induces remission in children with difficult to treat steroid resistant nephrotic syndrome from minimal change disease

被引：0
|
作者：
Maha Haddad
Arundhati Kale
Lavjay Butani
机构：
[1] University of California Davis,Section of Pediatric Nephrology
来源：
BMC Nephrology | / 22卷
关键词：
Steroid resistant nephrotic syndrome; Cyclophosphamide; Pediatric; Remission;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Efficacy of intravenous pulse cyclophosphamide treatment versus combination of intravenous dexamethasone and oral cyclophosphamide treatment in steroid-resistant nephrotic syndrome
    Mantan, Mukta
    Sriram, Chenni S.
    Hari, Pankaj
    Dinda, Amit
    Bagga, Arvind
    PEDIATRIC NEPHROLOGY, 2008, 23 (09) : 1495 - 1502
  • [32] Induction of remission with intravenous immunoglobulin and cyclophosphamide in steroid-resistant Evans' syndrome associated with dermatomyositis
    Chang, DK
    Yoo, DH
    Kim, TH
    Jun, JB
    Lee, IH
    Bae, SC
    Kim, IS
    Kim, SY
    CLINICAL RHEUMATOLOGY, 2001, 20 (01) : 63 - 66
  • [33] Induction of Remission with Intravenous Immunoglobulin and Cyclophosphamide in Steroid-Resistant Evans’ Syndrome Associated with Dermatomyositis
    Dae-Kook Chang
    Dae-Hyun Yoo
    Tae-Hwan Kim
    Jae-Bum Jun
    In-Hong Lee
    Sang-Cheol Bae
    In Soon Kim
    Seong Yoon Kim
    Clinical Rheumatology, 2001, 20 : 63 - 66
  • [34] Transition of severe diffuse mesangial hypercellularity to minimal change disease in a child with steroid-resistant nephrotic syndrome
    Fujinaga, S.
    Watanabe, T.
    Endo, A.
    Hirano, D.
    Ohtomo, Y.
    Shimizu, T.
    Kaneko, K.
    CLINICAL NEPHROLOGY, 2011, 76 (06) : 504 - 506
  • [35] Serum permeability activity in steroid-resistant minimal change nephrotic syndrome is abolished by treatment of Hodgkin disease
    Aggarwal, Nidhi
    Batwara, Ruchika
    McCarthy, Ellen T.
    Sharma, Ram
    Sharma, Mukut
    Savin, Virginia J.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 50 (05) : 826 - 829
  • [36] Necessity of cyclosporine for minimal change disease with transient remission during initial 4-week prednisolone treatment: is it steroid-sensitive or steroid-resistant nephrotic syndrome?
    Morishita, Toshimasa
    Fujinaga, Shuichiro
    Sakuraya, Koji
    PEDIATRIC NEPHROLOGY, 2025, 40 (01) : 265 - 266
  • [37] SUBCLINICAL CARDIOVASCULAR DISEASE IN CHILDREN WITH IDIOPATHIC STEROID RESISTANT NEPHROTIC SYNDROME
    Cengiz, Candan
    Nur, Canpolat
    Nurdan, Yildiz
    Selman, Gokalp
    Pinar, Turhan
    Mehmet, Tasdemir
    Lale, Sever
    Caliskan, Salim
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 421 - 421
  • [38] Subclinical cardiovascular disease in children with idiopathic steroid resistant nephrotic syndrome
    Candan, C.
    Canpolat, N.
    Gokalp, S.
    Yildiz, N.
    Turhan, P.
    Tasdemir, M.
    Sever, L.
    Caliskan, S.
    PEDIATRIC NEPHROLOGY, 2011, 26 (09) : 1709 - 1709
  • [39] Sustained complete remission of steroid- and cyclophosphamide-resistant minimal-change disease with a single course of rituximab therapy
    Janardan, Jyotsna
    Ooi, Khai
    Menahem, Solomon
    CLINICAL KIDNEY JOURNAL, 2014, 7 (03): : 293 - 295
  • [40] Minimal change (steroid sensitive) nephrotic syndrome in children: new aspects on pathogenesis and treatment
    Oh, J.
    Kemper, M. J.
    MINERVA PEDIATRICA, 2012, 64 (02) : 197 - 203
12345